Generic Name and Formulations:
Timolol (as hemihydrate) 0.25%, 0.5%; oph. soln; contains benzalkonium chloride.
Indications for BETIMOL:
1 drop twice daily.
Overt heart failure. Cardiogenic shock. Sinus bradycardia. 2nd- or 3rd-degree AV block. Asthma. Severe COPD.
Discontinue if heart failure develops and prior to surgery. Not for use as sole agent in narrow-angle glaucoma. Avoid abrupt cessation. Cerebrovascular insufficiency. Diabetes. COPD. Bronchospastic disease. May mask signs of hypoglycemia, thyrotoxicosis. Myasthenia gravis. Bacterial keratitis. Measure IOP after 4 wks of treatment. Pregnancy (Cat.C). Nursing mothers: not recommended.
May potentiate systemic β-blockers, reserpine. May cause conduction defects with calcium channel blockers, digitalis. May antagonize β-agonists. May block epinephrine.
Ocular irritation, eyelid erythema, conjunctival injection, headache, epiphora, photophobia. Systemic β-blocking effects (bradycardia, arrhythmias, hypotension, bronchospasm, heart failure).
Soln—5mL, 10mL, 15mL
- 5ml of 0.5% eye droppers (Qty:1)
- appx. price $79.00
- Recall of Two IV Antibiotics Announced
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- Peanut Allergy Patch Shows Promise in Latest Study
- IUD Approval Gives Women New Long-Acting Birth Control Option
- Number of Docs, Retail Clinics Affect Antibiotic Prescribing Rate
- More Evidence Points to the Power of Nuts in Reducing CVD Mortality
- Overactive Bladder Drug May be Beneficial in MS
- FDA to Review Investigational Parkinson's Disease Drug Xadago
- How Prevalent is Antipsychotic Prescribing in Seniors with Dementia?